Sangamo Therapeutics Inc (NASDAQ:SGMO)
| 0.5956 Delayed Data As of Sep 29 |  +0.0183 / +3.17%Today’s Change | 0.56 Today|||52-Week Range 5.17 | -81.03% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 39.5M | 19.4M | 36.6M | 84.5M | |
| Depreciation And Amortization | 988.0K | 997.0K | 1.5M | 2.4M | ||
| Operating Expenses | Gross Income | -- | -- | -- | -- | -- |
| General Expenses | 85.3M | 91.0M | 91.4M | 157.1M | ||
| Research And Development | 67.1M | 65.6M | 65.7M | 114.9M | ||
| Total Operating Expenses | 86.3M | 91.9M | 92.9M | 159.5M | ||
| Non-Operating Expenses | Operating Income | -46.8M | -72.6M | -56.4M | -75.1M | |
| Extraordinary Credit | 1.8M | 0.00 | 0.00 | 0.00 | ||
| Extraordinary Charge | -1.9M | 0.00 | 0.00 | -2.1M | ||
| Other Expenses | 431.0K | 0.00 | 0.00 | 0.00 | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -46.4M | -71.7M | -54.6M | -68.9M | |
| Income Taxes | -5.7M | -14.0K | 0.00 | 0.00 | ||
| Minority Interest | 0.00 | 0.00 | 0.00 | -555.0K | ||
| Net Income | -40.7M | -71.7M | -54.6M | -68.3M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 69.8M | 70.6M | 78.1M | 96.9M | |
| Shares To Calculate EPS Diluted | 69.8M | 70.6M | 78.1M | 96.9M | ||
| Earnings Per Share | EPS | -$0.58 | -$1.02 | -$0.70 | -$0.70 | |
| EPS Diluted | -$0.58 | -$1.02 | -$0.70 | -$0.70 | ||
